Driving MASH Drug Development & Navigating the Evolving Metabolic & Obesity Landscape
Event Dates
2024-09-24 - 2024-09-26
Organizer
Exhibitors
35
Floor Size
0
Attendees
120
Event contact title
Contact
Event contact first name
.
Event contact last name
.
Email
info@hansonwade.com
Event contact telephone number
UK: +44 (0)20 3141 8700 / US: +1 617 455 4188
Description
The 8th MASH Drug Development Summit unites 120+ industry leaders to address the most pressing challenges in MASH and metabolic diseases. Harnessing FGF21s, THR-β Agonists, GLP-1 Agonists, FXR & PPAR Agonists to propel your MASH therapeutic pieplines. This is your opportunity to access cutting-edge R&D insights that can super-charge your end-to-end metabolic development strategy.
Building on the momentum in the space from the recent FDA approval and GLP-1 blockbusters the 8th annual event will return to Boston this September 2024 to provide an update on the state of play and how to empower faster drug discovery and development.